Abivax SA (ABVX)
113.39
-0.91
(-0.80%)
USD |
NASDAQ |
Aug 28, 16:00
113.39
0.00 (0.00%)
After-Hours: 20:00
Abivax Market Cap : 8.991B for Aug. 28, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 27, 2026 | 9.063B |
| August 26, 2026 | 9.239B |
| August 25, 2026 | 9.351B |
| August 24, 2026 | 9.210B |
| August 21, 2026 | 9.115B |
| August 20, 2026 | 9.372B |
| August 19, 2026 | 9.559B |
| August 18, 2026 | 9.431B |
| August 17, 2026 | 9.573B |
| August 14, 2026 | 9.432B |
| August 13, 2026 | 9.630B |
| August 12, 2026 | 9.953B |
| August 11, 2026 | 10.05B |
| August 10, 2026 | 10.11B |
| August 07, 2026 | 10.38B |
| August 06, 2026 | 10.31B |
| August 05, 2026 | 9.942B |
| August 04, 2026 | 9.926B |
| August 03, 2026 | 9.894B |
| July 31, 2026 | 9.905B |
| July 30, 2026 | 9.858B |
| July 29, 2026 | 9.423B |
| July 28, 2026 | 9.850B |
| July 27, 2026 | 10.15B |
| July 24, 2026 | 9.967B |
| Date | Value |
|---|---|
| July 23, 2026 | 10.40B |
| July 22, 2026 | 10.29B |
| July 21, 2026 | 10.63B |
| July 20, 2026 | 10.43B |
| July 17, 2026 | 10.84B |
| July 16, 2026 | 10.92B |
| July 15, 2026 | 10.86B |
| July 14, 2026 | 10.70B |
| July 13, 2026 | 10.78B |
| July 10, 2026 | 11.09B |
| July 09, 2026 | 11.16B |
| July 08, 2026 | 10.99B |
| July 07, 2026 | 11.27B |
| July 06, 2026 | 11.42B |
| July 02, 2026 | 11.47B |
| July 01, 2026 | 10.51B |
| June 30, 2026 | 10.57B |
| June 29, 2026 | 7.624B |
| June 26, 2026 | 7.731B |
| June 25, 2026 | 7.324B |
| June 24, 2026 | 7.335B |
| June 23, 2026 | 7.805B |
| June 22, 2026 | 8.061B |
| June 18, 2026 | 7.862B |
| June 17, 2026 | 7.941B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Poxel SA | 13.94M |
| OSE Immunotherapeutics SA | 99.33M |
| Cogent Biosciences, Inc. | 5.961B |
| Compass Pathways Plc | 1.862B |
| Vera Therapeutics, Inc. | 2.462B |
Market Cap Related Metrics
| PEG Ratio | -0.0428 |
| Price to Book Value | 18.16 |
| Price | 113.39 |
| Earnings Yield | -4.63% |
| PEGY Ratio | -0.0428 |